Saturday 17 October 2026
Export MD’s income statement to Excel — free account
Pediatrix Medical Group, Inc.
MD Healthcare Medical Care Facilities
Pediatrix Medical Group, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.9 billion, down 4.92% from fiscal 2024. In the quarter to June 2026, revenue grew 4.04%, EPS grew 6.52%, free cash flow fell 6.56% and total debt fell 3.84%, each against the same quarter a year earlier.
27.38
0.38
−1.37%
Follow MD
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
19.13 | 15.87 | 11.26 | 0.00 | 0.00 | 17.78 | 18.78 | 0.00 | 0.00 | 11.03 |
Piotroski F-Score |
5 | 4 | 6 | 5 | 6 | 6 | 6 | 5 | 5 | 7 |
Altman Z-Score |
2.88 | 2.38 | 1.59 | 1.32 | 1.36 | 1.81 | 1.54 | 1.20 | 1.26 | 2.05 |
P/S ratio |
1.94 | 1.56 | 1.74 | 1.00 | 1.20 | 1.21 | 0.64 | 0.39 | 0.54 | 0.94 |
P/FCF ratio |
15.30 | 10.43 | 10.14 | 6.84 | 11.87 | 33.35 | 9.14 | 7.41 | 5.92 | 7.12 |
Altman Z″-Score (non-manufacturers) |
3.10 | 2.92 | 2.74 | 1.57 | 2.39 | 1.83 | 1.02 | 0.73 | 0.61 | 2.05 |
Beneish M-Score |
(2.51) | (2.54) | (2.20) | (3.10) | (3.37) | (2.00) | (2.53) | (2.90) | (3.29) | (2.86) |
P/Operating CF |
47.27 | 25.86 | 19.86 | 17.11 | (175.96) | 52.18 | 12.70 | 11.13 | 8.22 | 15.76 |
P/B ratio |
2.24 | 1.65 | 0.97 | 1.54 | 2.79 | 2.57 | 1.41 | 0.91 | 1.43 | 2.08 |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Sales |
2.46 | 2.10 | 2.85 | 1.67 | 1.50 | 1.48 | 0.91 | 0.62 | 0.68 | 0.99 |
EV/EBITDA |
11.76 | 12.69 | 17.72 | 15.05 | 19.47 | 11.80 | 8.58 | 27.42 | 0.00 | 8.19 |
EV/Operating CF |
17.64 | 13.38 | 15.66 | 10.86 | 12.73 | 36.83 | 10.79 | 8.93 | 6.60 | 6.99 |
EV/FCF |
19.35 | 14.10 | 16.57 | 11.48 | 14.81 | 40.83 | 13.13 | 11.79 | 7.38 | 7.51 |
Quick Ratio |
1.25 | 1.08 | 1.14 | 1.14 | 3.31 | 1.88 | 0.94 | 1.18 | 1.43 | 1.62 |
Current Ratio |
1.31 | 1.18 | 1.31 | 1.35 | 3.49 | 1.97 | 1.00 | 1.24 | 1.47 | 1.66 |
Net Debt/EBITDA |
2.46 | 3.31 | 6.88 | 7.70 | 3.86 | 2.16 | 2.61 | 10.19 | (7.57) | 0.42 |
Debt/Assets |
31.95% | 31.58% | 33.26% | 42.17% | 52.12% | 36.90% | 27.74% | 28.53% | 28.69% | 26.59% |
Debt/Equity |
0.62 | 0.60 | 0.64 | 1.17 | 2.33 | 1.12 | 0.73 | 0.75 | 0.81 | 0.69 |
Asset Turnover |
0.64 | 0.58 | 0.29 | 0.35 | 0.46 | 0.63 | 0.78 | 0.87 | 0.92 | 0.87 |
Operating CF/Net income |
1.37 | 1.60 | 1.17 | (0.24) | (0.26) | 0.59 | 2.52 | (2.27) | (2.09) | 1.64 |
Capex/Depreciation |
(0.42) | (0.31) | (0.59) | (0.61) | (0.81) | (0.21) | (0.79) | (0.89) | (0.66) | (0.81) |
Interest Coverage |
9.06 | 6.10 | 2.67 | 1.44 | 0.89 | 2.95 | 4.35 | 0.17 | (1.69) | 5.81 |
| 12.50% | 11.00% | 8.73% | (65.30%) | (70.90%) | 15.93% | 7.42% | (6.94%) | (12.28%) | 20.28% | |
| 6.57% | 5.72% | 4.55% | (29.71%) | (21.26%) | 4.31% | 2.62% | (2.65%) | (4.53%) | 7.52% | |
ROIC |
8.12% | 5.86% | 3.11% | 3.50% | 4.85% | 8.97% | 7.50% | 0.35% | (4.15%) | 13.55% |
Return on Tangible Assets |
134.68% | 146.06% | 108.47% | (570.84%) | (67.43%) | 27.09% | 89.28% | (35.50%) | (40.49%) | 48.11% |
Average Days of Receivables |
56.79 | 56.54 | 107.34 | 89.06 | 50.93 | 60.35 | 54.93 | 51.22 | 49.43 | 46.21 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
11.70% | 11.86% | 13.48% | 13.74% | 14.36% | 13.78% | 11.73% | 11.41% | 11.85% | 12.58% |
Intangible Assets out of Total Assets |
0.85 | 0.84 | 0.74 | 0.36 | 0.45 | 0.56 | 0.66 | 0.63 | 0.58 | 0.57 |
Share Based Compensation of Revenue |
1.07% | 0.88% | 2.12% | 1.88% | 2.25% | 0.99% | 0.82% | 0.62% | 0.59% | 0.94% |
Graham Net Nets |
(0.32) | (0.43) | (0.73) | (0.83) | (0.50) | (0.43) | (0.82) | (1.15) | (0.68) | (0.34) |
Graham Number |
48.50 | 50.75 | 47.27 | 0.00 | 0.00 | 19.08 | 13.87 | 0.00 | 0.00 | 21.20 |
Earnings Yield |
5.23% | 6.30% | 8.88% | (64.92%) | (38.75%) | 5.62% | 5.33% | (7.78%) | (9.15%) | 9.07% |
Free Cash Flow Yield |
6.54% | 9.59% | 9.87% | 14.62% | 8.42% | 3.00% | 10.95% | 13.49% | 16.88% | 14.05% |
Revenue per Share |
34.44 | 35.20 | 18.91 | 21.32 | 20.79 | 22.53 | 23.63 | 24.27 | 24.16 | 22.76 |
Operating CF per Share |
4.80 | 5.53 | 3.44 | 4.28 | 2.45 | 0.90 | 2.00 | 1.67 | 2.48 | 3.22 |
Capex per Share |
(0.42) | (0.28) | (0.19) | (0.23) | (0.35) | (0.09) | (0.36) | (0.41) | (0.26) | (0.22) |
Free Cash Flow per Share |
4.38 | 5.25 | 3.26 | 4.05 | 2.11 | 0.82 | 1.64 | 1.27 | 2.21 | 3.00 |
Cash per Share |
0.72 | 0.76 | 0.74 | 2.18 | 14.73 | 5.74 | 1.23 | 2.16 | 4.18 | 5.94 |
Shareholders Equity per Share |
29.87 | 33.18 | 33.89 | 17.95 | 8.97 | 10.57 | 10.68 | 10.33 | 9.18 | 10.30 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
29.87 | 33.18 | 33.89 | 17.95 | 8.97 | 10.57 | 10.68 | 10.33 | 9.18 | 10.30 |
Free Cash Flow |
404.51 | 485.23 | 296.59 | 338.44 | 175.83 | 69.22 | 137.23 | 104.00 | 184.55 | 252.63 |
Working Capital |
138.18 | 95.81 | 157.22 | 189.69 | 1,105.01 | 413.20 | 1.01 | 94.51 | 205.50 | 304.60 |
Capital Expenditures |
(39.26) | (26.15) | (17.12) | (19.27) | (28.79) | (7.52) | (29.71) | (33.33) | (22.02) | (18.46) |
Net Current Asset Value |
(1,991.50) | (2,173.59) | (2,189.62) | (1,915.40) | (1,050.88) | (985.29) | (1,028.27) | (887.29) | (748.15) | (617.33) |
EV/EBIT |
13.69 | 15.04 | 19.78 | 17.15 | 26.54 | 13.93 | 10.43 | 167.55 | 0.00 | 9.08 |
Capex to Sales |
0.01 | 0.01 | 0.01 | 0.01 | 0.02 | 0.00 | 0.02 | 0.02 | 0.01 | 0.01 |
Price to Operating Income |
10.83 | 11.12 | 12.10 | 10.22 | 21.28 | 11.38 | 7.26 | 105.32 | 0.00 | 8.61 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.91 | 0.68 | 0.32 | 0.43 | 0.47 | 0.52 | 0.51 | 0.49 | 0.85 | 0.58 |
Cash ROIC |
8.92% | 9.72% | 5.78% | 9.87% | 4.73% | 2.90% | 8.34% | 6.26% | 10.66% | 12.87% |
Accounts Receivable Turnover |
6.77 | 6.51 | 3.41 | 3.78 | 5.13 | 6.85 | 6.44 | 6.92 | 7.29 | 7.43 |
Accounts Payable Turnover |
5.35 | 5.52 | 2.75 | 2.97 | 3.08 | 3.42 | 3.92 | 4.34 | 4.16 | 3.47 |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Days of Payables |
69.27 | 68.51 | 134.41 | 117.40 | 120.24 | 102.90 | 90.76 | 81.40 | 93.37 | 107.83 |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Receivables |
470.01 | 499.64 | 505.36 | 470.49 | 338.10 | 278.98 | 306.41 | 288.33 | 276.24 | 257.46 |
Average Payables |
401.87 | 422.98 | 443.29 | 429.60 | 416.91 | 408.65 | 384.17 | 362.51 | 374.74 | 409.11 |
Average Assets |
4,943.31 | 5,603.34 | 5,902.38 | 5,041.69 | 3,746.92 | 3,035.25 | 2,535.22 | 2,283.85 | 2,186.26 | 2,199.70 |
Average Common Equity |
2,599.31 | 2,913.61 | 3,077.17 | 2,293.44 | 1,123.36 | 822.20 | 894.16 | 870.35 | 807.00 | 815.40 |
Columns are period end dates